Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol lozenges for sore throat pain in acute pharyngitis
NCT03583658Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in acute pharyngitis, sponsored by Sanofi. Started Jun 2018; status: completed.
02
Drugs
ambroxol
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on NCT03583658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03583658.